-
1
-
-
0028802261
-
Bleeding and thrombosis in myeloproliferative disorders: Mechanisms and treatment
-
Landolfi R, Rocca B, Patrono C. Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment. Critical Rev Oncol Hematol 1995; 20: 203-222.
-
(1995)
Critical Rev Oncol Hematol
, vol.20
, pp. 203-222
-
-
Landolfi, R.1
Rocca, B.2
Patrono, C.3
-
2
-
-
17844390356
-
Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera
-
DOI 10.1016/j.exphem.2005.01.015
-
Falanga A, Marchetti M, Vignoli A, et al. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol 2005; 33: 523-530. (Pubitemid 40592168)
-
(2005)
Experimental Hematology
, vol.33
, Issue.5
, pp. 523-530
-
-
Falanga, A.1
Marchetti, M.2
Vignoli, A.3
Balducci, D.4
Barbui, T.5
-
3
-
-
34247155769
-
V617F JAK-2 mutation in patients with essential thrombocythemia: Relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules
-
DOI 10.1016/j.exphem.2007.01.053, PII S0301472X07000975
-
Falanga A, Marchetti M, Vignoli A, et al. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules. Exp Hematol 2007; 35: 702-711. (Pubitemid 46601748)
-
(2007)
Experimental Hematology
, vol.35
, Issue.5
, pp. 702-711
-
-
Falanga, A.1
Marchetti, M.2
Vignoli, A.3
Balducci, D.4
Russo, L.5
Guerini, V.6
Barbui, T.7
-
4
-
-
25844477448
-
Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: The role of neutrophils
-
DOI 10.1053/j.seminhematol.2005.05.023, PII S0037196305000831
-
Falanga A, Marchetti M, Barbui T, et al. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils. Sem Hematol 2005; 42: 239-247. (Pubitemid 41400665)
-
(2005)
Seminars in Hematology
, vol.42
, Issue.4
, pp. 239-247
-
-
Falanga, A.1
Marchetti, M.2
Barbui, T.3
Smith, C.W.4
-
5
-
-
13444256042
-
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
-
DOI 10.1111/j.1365-2141.2004.05277.x
-
Elliott MA, Tefferi A. Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 2005; 128: 275-290. (Pubitemid 40216149)
-
(2005)
British Journal of Haematology
, vol.128
, Issue.3
, pp. 275-290
-
-
Elliott, M.A.1
Tefferi, A.2
-
6
-
-
0032525207
-
Endothelial cells in physiology and in the pathophysiology of vascular disorders
-
Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
-
(1998)
Blood
, vol.91
, pp. 3527-3561
-
-
Cines, D.B.1
Pollak, E.S.2
Buck, C.A.3
-
7
-
-
0034672149
-
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera
-
Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 2000; 96: 4261-4266.
-
(2000)
Blood
, vol.96
, pp. 4261-4266
-
-
Falanga, A.1
Marchetti, M.2
Evangelista, V.3
-
8
-
-
2142827032
-
Nitric oxide and its relationship to thrombotic disorders
-
Jun
-
Freedman JE, Loscalzo J. Nitric oxide and its relationship to thrombotic disorders. J Thromb Haemost 2003 Jun;1(6):1183-8.
-
(2003)
J Thromb Haemost
, vol.1
, Issue.6
, pp. 1183-1188
-
-
Freedman, J.E.1
Loscalzo, J.2
-
9
-
-
0027935309
-
Leukocyte-endothelial adhesion molecules
-
Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-2101.
-
(1994)
Blood
, vol.84
, pp. 2068-2101
-
-
Carlos, T.M.1
Harlan, J.M.2
-
10
-
-
0027486922
-
Circulating adhesion molecules in disease
-
Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
-
(1993)
Immunol Today
, vol.14
, pp. 506-512
-
-
Gearing, A.J.1
Newman, W.2
-
11
-
-
0034799502
-
Plasma markers of endothelial dysfunction in pulmonary hypertension
-
DOI 10.1378/chest.120.4.1226
-
Cella G, Bellotto F, Tona F, et al. Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 2001; 120: 1226-1230. (Pubitemid 32960098)
-
(2001)
Chest
, vol.120
, Issue.4
, pp. 1226-1230
-
-
Cella, G.1
Bellotto, F.2
Tona, F.3
Sbarai, A.4
Mazzaro, G.5
Motta, G.6
Fareed, J.7
-
12
-
-
0034987955
-
Adhesion molecules and their role in vascular disease
-
Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001; 14: 44S-54S.
-
(2001)
Am J Hypertens
, vol.14
-
-
Krieglstein, C.F.1
Granger, D.N.2
-
13
-
-
0028106054
-
Increased levels of the soluble adhesion molecule E-selectin in essential hypertension
-
Blann AD, Tse W, Maxwell SJ, et al. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994; 12: 925-928.
-
(1994)
J Hypertens
, vol.12
, pp. 925-928
-
-
Blann, A.D.1
Tse, W.2
Maxwell, S.J.3
-
14
-
-
0027104508
-
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance
-
Gearing AJ, Hemingway I, Pigott R, et al. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667: 324-331.
-
(1992)
Ann NY Acad Sci
, vol.667
, pp. 324-331
-
-
Gearing, A.J.1
Hemingway, I.2
Pigott, R.3
-
15
-
-
0029829853
-
Elevated circulating P-selectin in insulin dependent diabetes mellitus
-
Jilma B, Fasching P, Ruthner C, et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996; 76: 328-332.
-
(1996)
Thromb Haemost
, vol.76
, pp. 328-332
-
-
Jilma, B.1
Fasching, P.2
Ruthner, C.3
-
16
-
-
0030680163
-
Increased soluble P-selectin following myocardial infarction: A new marker for the progression of atherosclerosis
-
Blann AD, Faragher EB, McCollum CN. Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis. Blood Coagul Fibrinolysis 1997; 8: 383-390.
-
(1997)
Blood Coagul Fibrinolysis
, vol.8
, pp. 383-390
-
-
Blann, A.D.1
Faragher, E.B.2
McCollum, C.N.3
-
17
-
-
33745728731
-
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders
-
Michiels JJ, De Raeve H, Berneman Z, et al. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders. Semin Thromb Hemost 2006; 32: 307-340.
-
(2006)
Semin Thromb Hemost
, vol.32
, pp. 307-340
-
-
Michiels, J.J.1
De Raeve, H.2
Berneman, Z.3
-
18
-
-
1842587604
-
Nitric oxide and its role in ischaemic brain injury
-
Keynes RG, Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 2004; 4: 179-191.
-
(2004)
Curr Mol Med
, vol.4
, pp. 179-191
-
-
Keynes, R.G.1
Garthwaite, J.2
-
19
-
-
0032977037
-
Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea
-
Glover RE, Ivy ED, Orringer EP, et al. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol 1999; 55: 1006-1010.
-
(1999)
Mol Pharmacol
, vol.55
, pp. 1006-1010
-
-
Glover, R.E.1
Ivy, E.D.2
Orringer, E.P.3
-
20
-
-
0028913012
-
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
-
Cortelazzo S, Finazzi G, Ruggeri M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. New Engl J Med 1995; 332: 1132-1136.
-
(1995)
New Engl J Med
, vol.332
, pp. 1132-1136
-
-
Cortelazzo, S.1
Finazzi, G.2
Ruggeri, M.3
-
21
-
-
0141455884
-
Effects of in vitro platelet activation on platelet derived nitric oxide production in healthy humans and in chronic myeloproliferative diseases with elevated platelet counts
-
Rejto L, Huszka M, Kaplar M, et al. Effects of in vitro platelet activation on platelet derived nitric oxide production in healthy humans and in chronic myeloproliferative diseases with elevated platelet counts. Platelets 2003; 14: 283-286.
-
(2003)
Platelets
, vol.14
, pp. 283-286
-
-
Rejto, L.1
Huszka, M.2
Kaplar, M.3
-
22
-
-
0032460243
-
Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal and vasculopathic subjects
-
Ferlito S, Gallina M. Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal and vasculopathic subjects. Minerva Cardioangiologica 1998; 46: 471-477.
-
(1998)
Minerva Cardioangiologica
, vol.46
, pp. 471-477
-
-
Ferlito, S.1
Gallina, M.2
-
23
-
-
66549098913
-
Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction
-
Kayali Z, Herring J, Baron P, et al. Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction. J Gastroenterol Hepatol 2009; 24: 1030-1037.
-
(2009)
J Gastroenterol Hepatol
, vol.24
, pp. 1030-1037
-
-
Kayali, Z.1
Herring, J.2
Baron, P.3
-
24
-
-
57049135827
-
Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction
-
Caimi G, Montana M, Calandrino V, et al. Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction. Clin Hemorheol Microcirculation 2008; 40: 157-163.
-
(2008)
Clin Hemorheol Microcirculation
, vol.40
, pp. 157-163
-
-
Caimi, G.1
Montana, M.2
Calandrino, V.3
-
25
-
-
0037804764
-
Hemostasis and coagulation at a hematocrit level of 0.85: Functional consequences of erythrocytosis
-
Shibata J, Hasegawa J, Siemens HJ, et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 2003; 101: 4416-4422.
-
(2003)
Blood
, vol.101
, pp. 4416-4422
-
-
Shibata, J.1
Hasegawa, J.2
Siemens, H.J.3
-
26
-
-
3442884607
-
P-selectin in haemostasis
-
Andre P. P-selectin in haemostasis. Br J Haematol 2004; 126: 298-306.
-
(2004)
Br J Haematol
, vol.126
, pp. 298-306
-
-
Andre, P.1
-
27
-
-
2442555214
-
Markers of Endothelial and in Vivo Platelet Activation in Patients with Essential Thrombocythemia and Polycythemia Vera
-
Karakantza M, Giannakoulas NC, Zikos P, et al. Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera. Int J Hematol 2004; 79: 253-259. (Pubitemid 38620775)
-
(2004)
International Journal of Hematology
, vol.79
, Issue.3
, pp. 253-259
-
-
Karakantza, M.1
Giannakoulas, N.C.2
Zikos, P.3
Sakellaropoulos, G.4
Kouraklis, A.5
Aktypi, A.6
Metallinos, I.C.7
Theodori, E.8
Zoumbos, N.C.9
Maniatis, A.10
-
28
-
-
0033976695
-
Markers of endothelial and platelet status in patients with essential thrombocythemia and polycythemia vera
-
Musolino C, Alonci A, Bellomo G, et al. Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. Hematology (Amsterdam, Netherlands) 2000; 4: 397-402. (Pubitemid 30098759)
-
(2000)
Hematology
, vol.4
, Issue.5
, pp. 397-402
-
-
Musolino, C.1
Alonci, A.2
Bellomo, G.3
Tringali, O.4
Spatari, G.5
Quartarone, C.6
Rizzo, V.7
Calabro, L.8
Bagnato, G.9
Frisina, N.10
-
29
-
-
0031844696
-
Kinetics of circulating selectin levels during bone marrow aplasia
-
Jilma B, Eichler HG, Becherer A, et al. Kinetics of circulating selectin levels during bone marrow aplasia. Eur J Haematol 1998; 61: 36-41. (Pubitemid 28326401)
-
(1998)
European Journal of Haematology
, vol.61
, Issue.1
, pp. 36-41
-
-
Jilma, B.1
Eichler, H.G.2
Becherer, A.3
Brugger, S.4
Kalhs, P.5
Stohlawetz, P.6
Kapiotis, S.7
Kapiotis, S.8
-
30
-
-
62549140121
-
Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation
-
Bang SM, Lee JS, Ahn JY, et al. Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation. Thromb Haemost 2009; 101: 547-551.
-
(2009)
Thromb Haemost
, vol.101
, pp. 547-551
-
-
Bang, S.M.1
Lee, J.S.2
Ahn, J.Y.3
-
31
-
-
33947262701
-
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: Interaction with treatment, standard risk factors, and Jak2 mutation status
-
DOI 10.1182/blood-2006-09-046342
-
Carobbio A, Finazzi G, Guerini V, et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood 2007; 109: 2310-2313. (Pubitemid 46425868)
-
(2007)
Blood
, vol.109
, Issue.6
, pp. 2310-2313
-
-
Carobbio, A.1
Finazzi, G.2
Guerini, V.3
Spinelli, O.4
Delaini, F.5
Marchioli, R.6
Borrelli, G.7
Rambaldi, A.8
Barbui, T.9
|